This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Wai Yuen Tong Medicine Holdings Limited commences an Equity Buyback Plan for 117,110,288 shares, representing 10% of its issued share capital, under the authorization approved on August 22, 2023. CI
Wai Yuen Tong Medicine Holdings Limited Announces Changes of Company Secretary, with Effect from 1 April 2024 CI
Wai Yuen Tong Medicine Unit to Sell Properties in Hong Kong MT
Wai Yuen Tong Medicine Plans Special Dividend of Wang On, China Agri-Products Shares; Shares Up 7% MT
Wai Yuen Tong Medicine Holdings Limited agreed to Spin-Off Wang On Group Limited. CI
Wai Yuen Tong to Buy Shop Space in Hong Kong MT
Wai Yuen Tong Medicine Shareholders to Vote Jan. 30 on Granting of Loan Facility to Wang On MT
Tranche Update on Wai Yuen Tong Medicine Holdings Limited's Equity Buyback Plan announced on September 1, 2022. CI
Wai Yuen Tong Medicine to Extend Revolving Loan Facility to Wang On MT
Wai Yuen Tong Medicine Holdings Limited Announces Change of Independent Non-Executive Directors and Change in Compositions of Board Committees CI
Wai Yuen Tong Medicine Returns to Profit in Fiscal H1 MT
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Wai Yuen Tong Medicine Subsidiary Sells Stake in Owner of Leased Shops MT
Wai Yuen Tong Medicine to Return to Profit in Fiscal H1 MT
Wai Yuen Tong Medicine Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 September 2023 CI
Wai Yuen Tong Medicine Holdings Limited's Equity Buyback announced on September 1, 2022, has expired with 60,540,000 shares, representing 4.98% for HKD 24.69 million. CI
Wai Yuen Tong Medicines' Fiscal Year 2023 Loss Narrows MT
Tranche Update on Wai Yuen Tong Medicine Holdings Limited's Equity Buyback Plan announced on September 1, 2022. CI
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Wai Yuen Tong Medicine to Narrow Full-Year Loss MT
Wai Yuen Tong Medicine Holdings Limited Provides Earnings Guidance for the Financial Year Ended 31 March 2023 CI
Wai Yuen Tong Medicine, Wang On Sell Hong Kong Factory for HK$71 Million MT
Lei Wa entered into the Provisional Agreement to acquire Billion Good Investment Limited from Wai Yuen Tong Medicine Holdings Limited and Wang On Limited for HKD 71 million. CI
Wai Yuen Tong Medicine Sells Hong Kong Property for HK$49 Million MT
Wai Yuen Tong Medicine Swings to Loss in April-September MT
Chart Wai Yuen Tong Medicine Holdings Limited
More charts
Wai Yuen Tong Medicine Holdings Limited is a Hong Kong-based investment holding company principally engaged in the production and sales of pharmaceutical products. The Company operates through three segments. Production and Sale of Chinese Pharmaceutical and Health Food Products segment is mainly engaged in the manufacture, processing and retailing of traditional Chinese medicine in China and Hong Kong. Its products include Chinese medicines under the brand Wai Yuen Tong, as well as products manufactured with traditional prescriptions. Production and Sale of Western Pharmaceutical and Health Food Products segment is engaged in the processing and sales of Western pharmaceutical products and personal care products under the brands Madame Pearl’s and Pearl’s. Property Investment segment is engaged in the investment in commercial properties for rental income.
More about the company
  1. Stock Market
  2. Equities
  3. 897 Stock
  4. News Wai Yuen Tong Medicine Holdings Limited
  5. Wai Yuen Tong Medicine : Subsidiary Acquires $5 Million Worth of Bonds for Treasury Activities